NCT00015483已完成不适用
Hematotoxic Effects of Benzene and Doxorubicin
National Institute of Environmental Health Sciences (NIEHS)0 个研究点开始时间: 2001年4月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
Hematotoxicity is caused by a number of agents such as a benzene by-product called hydroquinone and the antitumor agent doxorubicin. This is a basic research study, conducted using normal human donors, of mechanisms involved in hematotoxicity and of the protective response of human hematopoietic progenitor cells to hematotoxic agents. Tumor necrosis factor exposure protects these cells from a subsequent exposure to hematotoxic agents. The alteration of gene expression in these cells caused by tumor necrosis factor is being studied. Additionally, the tumor necrosis factor-induced biochemical pathways involved in protection of human hematopoietic progenitor cells will be studied.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 55 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)HematotoxicityHematological AbnormalityNCT03828942Groupe Hospitalier Pitie-Salpetriere1,000
已完成
不适用
Protection Against Benzene ToxicityAplastic AnemiaLeukemiaNCT00011453National Institute of Environmental Health Sciences (NIEHS)
已完成
2 期
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell CarcinomaMetastatic Renal Cell CarcinomaRenal Cell Carcinoma With Sarcomatoid FeaturesNCT00068393Eastern Cooperative Oncology Group39
已完成
2 期
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell LymphomaLymphomaNCT00255801Memorial Sloan Kettering Cancer Center37
终止
2 期
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue SarcomaSarcomaNCT01189253European Organisation for Research and Treatment of Cancer - EORTC133
